Search Results - "Kamura, T"
-
1
Phase III randomised controlled trial of neoadjuvant chemotherapy plus radical surgery vs radical surgery alone for stages IB2, IIA2, and IIB cervical cancer: a Japan Clinical Oncology Group trial (JCOG 0102)
Published in British journal of cancer (28-05-2013)“…Background: A phase III trial was conducted to determine whether neoadjuvant chemotherapy (NACT) before radical surgery (RS) improves overall survival…”
Get full text
Journal Article -
2
Expression of activated signal transducer and activator of transcription-3 predicts poor prognosis in cervical squamous-cell carcinoma
Published in British journal of cancer (15-09-2009)“…Background: Stat3 is a member of the Janus-activated kinase/STAT signalling pathway. It normally resides in the cytoplasm and can be activated through…”
Get full text
Journal Article -
3
Efficacy of neoadjuvant chemotherapy in patients with FIGO stage IB1 to IIA cervical cancer: An international collaborative meta-analysis
Published in European journal of surgical oncology (01-02-2013)“…Abstract Background The efficacy of neoadjuvant chemotherapy before surgery (NCS) has not been well-established in FIGO stage IB1 to IIA cervical cancer when…”
Get full text
Journal Article -
4
Rbx1, a Component of the VHL Tumor Suppressor Complex and SCF Ubiquitin Ligase
Published in Science (American Association for the Advancement of Science) (23-04-1999)“…The von Hippel-Lindau (VHL) tumor suppressor gene is mutated in most human kidney cancers. The VHL protein is part of a complex that includes Elongin B,…”
Get full text
Journal Article -
5
The Rbx1 subunit of SCF and VHL E3 ubiquitin ligase activates Rub1 modification of cullins Cdc53 and Cul2
Published in Genes & development (15-11-1999)“…The RING-H2 finger protein Rbx1 is a subunit of the related SCF (Skp1-Cdc53/Cul1-F-box protein) and von Hippel-Lindau (VHL) tumor suppressor (elongin…”
Get full text
Journal Article -
6
A Consensus-based Guideline Defining the Clinical Target Volume for Pelvic Lymph Nodes in External Beam Radiotherapy for Uterine Cervical Cancer
Published in Japanese journal of clinical oncology (01-05-2010)“…Objective To develop a consensus-based guideline as well as an atlas defining pelvic nodal clinical target volumes in external beam radiotherapy for uterine…”
Get full text
Journal Article Conference Proceeding -
7
Prognostic factors for stage IVB persistent or recurrent cervical cancer (from the results of the JCOG0505 Trial)
Published in Gynecologic oncology (01-07-2013)Get full text
Journal Article -
8
Dynamics of placental ghrelin production and its receptor expression in a Dahl salt-sensitive rat model of intrauterine growth restriction
Published in Placenta (Eastbourne) (01-05-2010)“…Abstract Background Ghrelin, a peptide hormone produced mainly in the stomach, is an endogenous ligand for the growth hormone secretagogue receptor (GHS-R)…”
Get full text
Journal Article -
9
A Phase III Trial of Paclitaxel plus Carboplatin Versus Paclitaxel plus Cisplatin in Stage IVB, Persistent or Recurrent Cervical Cancer: Gynecologic Cancer Study Group/Japan Clinical Oncology Group Study (JCOG0505)
Published in Japanese journal of clinical oncology (01-01-2010)“…A randomized controlled trial has been started in Japan to compare the utility of palliative chemotherapy containing paclitaxel and carboplatin (TC) with…”
Get full text
Journal Article -
10
-
11
Phase III Trial of Upfront Debulking Surgery Versus Neoadjuvant Chemotherapy for Stage III/IV Ovarian, Tubal and Peritoneal Cancers: Japan Clinical Oncology Group Study JCOG0602
Published in Japanese journal of clinical oncology (01-01-2008)“…On the basis of promising results of neoadjuvant chemotherapy (NAC) in our previous study (JCOG0206), we have been performing a Phase III study of treatment…”
Get full text
Journal Article -
12
W167 CHARACTERISTICS OF PREGNANT WOMEN WITH ONE ABNORMAL VALUE ON 75-G ORAL GLUCOSE TOLERANCE TEST
Published in International journal of gynecology and obstetrics (01-10-2012)Get full text
Journal Article -
13
Cytological nuclear atypia classification can predict prognosis in patients with endometrial cancer
Published in Cytopathology (Oxford) (01-06-2015)“…Objective Endometrial cancer is one of the leading causes of malignancy in females. Nuclear findings are important for patients with cancer, and can provide…”
Get full text
Journal Article -
14
W085 A CASE OF SINUSOIDAL PATTERN OBSERVED DURING ADMINISTRATION OF MAGNESIUM SULFATE
Published in International journal of gynecology and obstetrics (01-10-2012)Get full text
Journal Article -
15
8042 POSTER Nuclear Y-box Binding Protein-1 Expression, a Predictive Marker of Prognosis, Is Correlated With Activated Signal Transducer and Activator of Transcription-3 Expression and Survival in Cervical Squamous-cell Carcinoma
Published in European journal of cancer (1990) (2011)Get full text
Journal Article -
16
The History of the Gynecologic Cancer Study Group (GCSG) of the Japan Clinical Oncology Group (JCOG)
Published in Japanese journal of clinical oncology (01-10-2011)“…The Gynecologic Cancer Study Group (GCSG) of the Japan Clinical Oncology Group (JCOG) was organized in 1994. The GCSG has developed under the leadership of…”
Get full text
Journal Article -
17
Co-expression of Y box-binding protein-1 and P-glycoprotein as a prognostic marker for survival in epithelial ovarian cancer
Published in Gynecologic oncology (01-05-2004)“…Objectives. This study aimed to observe the expressions of Y box-binding protein-1 (YB-1) and P-glycoprotein (P-gp) in primary ovarian tumor and to determine…”
Get full text
Journal Article -
18
UDP-Gal: βGlcNAc β1, 3-galactosyltransferase, polypeptide 3 (GALT3) is a tumour antigen recognised by HLA-A2-restricted cytotoxic T lymphocytes from patients with brain tumour
Published in British journal of cancer (21-10-2002)“…Patient prognosis in the case of malignant brain tumours is generally poor, despite significant improvements in the early detection of the tumours, and thus…”
Get full text
Journal Article -
19
Detection of peptide-specific CTL-precursors in peripheral blood lymphocytes of cancer patients
Published in British journal of cancer (23-09-2002)“…Development of therapeutic vaccines is one of the major areas of tumour immunotherapy today. However, clinical trials of peptide-based cancer vaccines have…”
Get full text
Journal Article -
20
Tumor-associated antigen 22-1-1 expression in the uterine cervical squamous neoplasias
Published in Clinical cancer research (01-06-1998)“…We have reported that a novel tumor-associated antigen (Ag), 22-1-1, was expressed in cancer cells derived mainly from the uterus and ovary [K. Sonoda et al.,…”
Get full text
Journal Article